Weight-loss drug developer Metsera valued at $2.68 bln as shares jumped in market debut
Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...
Bill McEwen1h
About Half of Americans Approve of Using Weight-Loss Drugs to Treat Obesity, Poll Finds
New poll reveals Americans' mixed views on weight-loss drugs for obesity treatment, especially regarding teen use.
Healio1h
Most adults with overweight or obesity discontinue GLP-1 therapy within 2 years
More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...
Half of Americans Support Weight-Loss Drugs Like Ozempic for Obesity, Poll
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
WKTV2h
National and International News in Focus: Jan.31
Police boats have returned to the Potomac River as part of the recovery and investigation after the United States’ deadliest ...
Jelly Roll showcases 120lbs weight loss during emotional new appearance
Jelly Roll showed off his 120lbs weight loss as he performed at the FireAid Benefit Concert for California Fire Relief in Los ...
Ozempic trims fat — from grocery bills
Ozempic, the diabetes medication popularly used as an “off-label” weight-loss drug, has helped thousands shed excess pounds.
With a “thumbs down” celebration befitting his personality, Julian Strawther is finding his place in Nuggets rotation
Picked 29th overall in the 2023 draft, Strawther arrived in Denver and quickly endeared himself to young teammates.
Ozempic May Protect Against Alzheimer’s
One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...